nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Ritonavir—acquired immunodeficiency syndrome	0.121	0.389	CrCtD
Atazanavir—Cytochrome P450 3A Inhibitors—Saquinavir—acquired immunodeficiency syndrome	0.0991	0.321	CiPCiCtD
Atazanavir—Lopinavir—acquired immunodeficiency syndrome	0.0989	0.317	CrCtD
Atazanavir—Saquinavir—acquired immunodeficiency syndrome	0.0919	0.295	CrCtD
Atazanavir—Cytochrome P450 3A Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.0751	0.243	CiPCiCtD
Atazanavir—Cytochrome P450 3A Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0455	0.147	CiPCiCtD
Atazanavir—Ritonavir—Lopinavir—acquired immunodeficiency syndrome	0.0375	0.197	CrCrCtD
Atazanavir—Cytochrome P450 3A4 Inhibitors—Amprenavir—acquired immunodeficiency syndrome	0.0367	0.119	CiPCiCtD
Atazanavir—Lopinavir—Ritonavir—acquired immunodeficiency syndrome	0.0306	0.161	CrCrCtD
Atazanavir—Lopinavir—Indinavir—acquired immunodeficiency syndrome	0.0272	0.143	CrCrCtD
Atazanavir—Saquinavir—Nelfinavir—acquired immunodeficiency syndrome	0.0264	0.139	CrCrCtD
Atazanavir—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0261	0.0847	CiPCiCtD
Atazanavir—Cytochrome P450 3A4 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.0261	0.0847	CiPCiCtD
Atazanavir—Saquinavir—Indinavir—acquired immunodeficiency syndrome	0.0235	0.124	CrCrCtD
Atazanavir—Lopinavir—Saquinavir—acquired immunodeficiency syndrome	0.0232	0.122	CrCrCtD
Atazanavir—Saquinavir—Lopinavir—acquired immunodeficiency syndrome	0.0215	0.113	CrCrCtD
Atazanavir—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0146	0.109	CbGbCtD
Atazanavir—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0126	0.0938	CbGbCtD
Atazanavir—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0111	0.0823	CbGbCtD
Atazanavir—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0111	0.0823	CbGbCtD
Atazanavir—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0082	0.0611	CbGbCtD
Atazanavir—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00427	0.0318	CbGbCtD
Atazanavir—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00401	0.0299	CbGbCtD
Atazanavir—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00401	0.0299	CbGbCtD
Atazanavir—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00389	0.029	CbGbCtD
Atazanavir—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00363	0.027	CbGbCtD
Atazanavir—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00363	0.027	CbGbCtD
Atazanavir—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00352	0.0262	CbGbCtD
Atazanavir—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00313	0.0233	CbGbCtD
Atazanavir—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00304	0.0226	CbGbCtD
Atazanavir—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00304	0.0226	CbGbCtD
Atazanavir—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00295	0.022	CbGbCtD
Atazanavir—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00275	0.0205	CbGbCtD
Atazanavir—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00275	0.0205	CbGbCtD
Atazanavir—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00267	0.0199	CbGbCtD
Atazanavir—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00267	0.0199	CbGbCtD
Atazanavir—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00264	0.0196	CbGbCtD
Atazanavir—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00256	0.019	CbGbCtD
Atazanavir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00248	0.0185	CbGbCtD
Atazanavir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00233	0.0174	CbGbCtD
Atazanavir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00233	0.0174	CbGbCtD
Atazanavir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00211	0.0157	CbGbCtD
Atazanavir—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00211	0.0157	CbGbCtD
Atazanavir—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00198	0.0147	CbGbCtD
Atazanavir—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00182	0.0136	CbGbCtD
Atazanavir—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00177	0.0132	CbGbCtD
Atazanavir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.0119	CbGbCtD
Atazanavir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0016	0.0119	CbGbCtD
Atazanavir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00153	0.0114	CbGbCtD
Atazanavir—Saquinavir—ALB—acquired immunodeficiency syndrome	1.58e-05	1	CrCbGaD
Atazanavir—Syncope—Saquinavir—acquired immunodeficiency syndrome	1.31e-05	0.000239	CcSEcCtD
Atazanavir—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	1.31e-05	0.000238	CcSEcCtD
Atazanavir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	1.31e-05	0.000238	CcSEcCtD
Atazanavir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	1.3e-05	0.000237	CcSEcCtD
Atazanavir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	1.3e-05	0.000237	CcSEcCtD
Atazanavir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	1.3e-05	0.000237	CcSEcCtD
Atazanavir—Pruritus—Stavudine—acquired immunodeficiency syndrome	1.3e-05	0.000237	CcSEcCtD
Atazanavir—Asthenia—Abacavir—acquired immunodeficiency syndrome	1.3e-05	0.000236	CcSEcCtD
Atazanavir—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	1.3e-05	0.000236	CcSEcCtD
Atazanavir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	1.3e-05	0.000236	CcSEcCtD
Atazanavir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	1.29e-05	0.000236	CcSEcCtD
Atazanavir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	1.29e-05	0.000236	CcSEcCtD
Atazanavir—Chest pain—Ritonavir—acquired immunodeficiency syndrome	1.29e-05	0.000236	CcSEcCtD
Atazanavir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	1.29e-05	0.000235	CcSEcCtD
Atazanavir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	1.29e-05	0.000235	CcSEcCtD
Atazanavir—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	1.29e-05	0.000234	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	1.29e-05	0.000234	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Pruritus—Abacavir—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Fatigue—Indinavir—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Cough—Saquinavir—acquired immunodeficiency syndrome	1.28e-05	0.000233	CcSEcCtD
Atazanavir—Angioedema—Lamivudine—acquired immunodeficiency syndrome	1.28e-05	0.000232	CcSEcCtD
Atazanavir—Constipation—Indinavir—acquired immunodeficiency syndrome	1.27e-05	0.000231	CcSEcCtD
Atazanavir—Pain—Indinavir—acquired immunodeficiency syndrome	1.27e-05	0.000231	CcSEcCtD
Atazanavir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	1.27e-05	0.000231	CcSEcCtD
Atazanavir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	1.27e-05	0.000231	CcSEcCtD
Atazanavir—Convulsion—Saquinavir—acquired immunodeficiency syndrome	1.27e-05	0.000231	CcSEcCtD
Atazanavir—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	1.27e-05	0.000231	CcSEcCtD
Atazanavir—Hypertension—Saquinavir—acquired immunodeficiency syndrome	1.26e-05	0.00023	CcSEcCtD
Atazanavir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	1.26e-05	0.00023	CcSEcCtD
Atazanavir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	1.26e-05	0.00023	CcSEcCtD
Atazanavir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	1.26e-05	0.00023	CcSEcCtD
Atazanavir—Malaise—Lamivudine—acquired immunodeficiency syndrome	1.26e-05	0.000229	CcSEcCtD
Atazanavir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	1.26e-05	0.000229	CcSEcCtD
Atazanavir—Nausea—Didanosine—acquired immunodeficiency syndrome	1.26e-05	0.000229	CcSEcCtD
Atazanavir—Syncope—Lamivudine—acquired immunodeficiency syndrome	1.25e-05	0.000228	CcSEcCtD
Atazanavir—Confusional state—Ritonavir—acquired immunodeficiency syndrome	1.25e-05	0.000228	CcSEcCtD
Atazanavir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	1.25e-05	0.000228	CcSEcCtD
Atazanavir—Somnolence—Efavirenz—acquired immunodeficiency syndrome	1.25e-05	0.000227	CcSEcCtD
Atazanavir—Chest pain—Saquinavir—acquired immunodeficiency syndrome	1.25e-05	0.000227	CcSEcCtD
Atazanavir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	1.25e-05	0.000227	CcSEcCtD
Atazanavir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	1.25e-05	0.000227	CcSEcCtD
Atazanavir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	1.24e-05	0.000226	CcSEcCtD
Atazanavir—Oedema—Ritonavir—acquired immunodeficiency syndrome	1.24e-05	0.000226	CcSEcCtD
Atazanavir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	1.24e-05	0.000225	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	1.24e-05	0.000225	CcSEcCtD
Atazanavir—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	1.23e-05	0.000225	CcSEcCtD
Atazanavir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.000224	CcSEcCtD
Atazanavir—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	1.23e-05	0.000223	CcSEcCtD
Atazanavir—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	1.22e-05	0.000223	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	1.22e-05	0.000223	CcSEcCtD
Atazanavir—Shock—Ritonavir—acquired immunodeficiency syndrome	1.22e-05	0.000222	CcSEcCtD
Atazanavir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	1.22e-05	0.000222	CcSEcCtD
Atazanavir—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	1.22e-05	0.000222	CcSEcCtD
Atazanavir—Cough—Lamivudine—acquired immunodeficiency syndrome	1.22e-05	0.000222	CcSEcCtD
Atazanavir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	1.22e-05	0.000222	CcSEcCtD
Atazanavir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	1.22e-05	0.000222	CcSEcCtD
Atazanavir—Dizziness—Stavudine—acquired immunodeficiency syndrome	1.21e-05	0.000221	CcSEcCtD
Atazanavir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	1.21e-05	0.000221	CcSEcCtD
Atazanavir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	1.21e-05	0.000221	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	1.21e-05	0.00022	CcSEcCtD
Atazanavir—Convulsion—Lamivudine—acquired immunodeficiency syndrome	1.21e-05	0.00022	CcSEcCtD
Atazanavir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	1.21e-05	0.00022	CcSEcCtD
Atazanavir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	1.21e-05	0.00022	CcSEcCtD
Atazanavir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	1.21e-05	0.000219	CcSEcCtD
Atazanavir—Confusional state—Saquinavir—acquired immunodeficiency syndrome	1.2e-05	0.000219	CcSEcCtD
Atazanavir—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Pain—Efavirenz—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Constipation—Efavirenz—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Rash—Nevirapine—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Dizziness—Abacavir—acquired immunodeficiency syndrome	1.2e-05	0.000218	CcSEcCtD
Atazanavir—Oedema—Saquinavir—acquired immunodeficiency syndrome	1.19e-05	0.000218	CcSEcCtD
Atazanavir—Somnolence—Delavirdine—acquired immunodeficiency syndrome	1.19e-05	0.000217	CcSEcCtD
Atazanavir—Headache—Nevirapine—acquired immunodeficiency syndrome	1.19e-05	0.000217	CcSEcCtD
Atazanavir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	1.19e-05	0.000216	CcSEcCtD
Atazanavir—Chest pain—Lamivudine—acquired immunodeficiency syndrome	1.19e-05	0.000216	CcSEcCtD
Atazanavir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	1.19e-05	0.000216	CcSEcCtD
Atazanavir—Infection—Saquinavir—acquired immunodeficiency syndrome	1.19e-05	0.000216	CcSEcCtD
Atazanavir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	1.18e-05	0.000216	CcSEcCtD
Atazanavir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	1.18e-05	0.000215	CcSEcCtD
Atazanavir—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	1.18e-05	0.000215	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	1.18e-05	0.000215	CcSEcCtD
Atazanavir—Urticaria—Indinavir—acquired immunodeficiency syndrome	1.18e-05	0.000215	CcSEcCtD
Atazanavir—Shock—Saquinavir—acquired immunodeficiency syndrome	1.18e-05	0.000214	CcSEcCtD
Atazanavir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	1.17e-05	0.000214	CcSEcCtD
Atazanavir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	1.17e-05	0.000214	CcSEcCtD
Atazanavir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	1.17e-05	0.000214	CcSEcCtD
Atazanavir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	1.17e-05	0.000213	CcSEcCtD
Atazanavir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	1.17e-05	0.000213	CcSEcCtD
Atazanavir—Vomiting—Stavudine—acquired immunodeficiency syndrome	1.17e-05	0.000213	CcSEcCtD
Atazanavir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	1.17e-05	0.000212	CcSEcCtD
Atazanavir—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	1.16e-05	0.000212	CcSEcCtD
Atazanavir—Rash—Nelfinavir—acquired immunodeficiency syndrome	1.16e-05	0.000212	CcSEcCtD
Atazanavir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	1.16e-05	0.000211	CcSEcCtD
Atazanavir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	1.16e-05	0.000211	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	1.16e-05	0.000211	CcSEcCtD
Atazanavir—Rash—Stavudine—acquired immunodeficiency syndrome	1.16e-05	0.000211	CcSEcCtD
Atazanavir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	1.16e-05	0.000211	CcSEcCtD
Atazanavir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	1.16e-05	0.000211	CcSEcCtD
Atazanavir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	1.16e-05	0.00021	CcSEcCtD
Atazanavir—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	1.15e-05	0.00021	CcSEcCtD
Atazanavir—Headache—Nelfinavir—acquired immunodeficiency syndrome	1.15e-05	0.00021	CcSEcCtD
Atazanavir—Headache—Stavudine—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Vomiting—Abacavir—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Confusional state—Lamivudine—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Constipation—Delavirdine—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Pain—Delavirdine—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	1.15e-05	0.000209	CcSEcCtD
Atazanavir—Rash—Abacavir—acquired immunodeficiency syndrome	1.14e-05	0.000208	CcSEcCtD
Atazanavir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	1.14e-05	0.000208	CcSEcCtD
Atazanavir—Oedema—Lamivudine—acquired immunodeficiency syndrome	1.14e-05	0.000207	CcSEcCtD
Atazanavir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	1.14e-05	0.000207	CcSEcCtD
Atazanavir—Headache—Abacavir—acquired immunodeficiency syndrome	1.13e-05	0.000206	CcSEcCtD
Atazanavir—Infection—Lamivudine—acquired immunodeficiency syndrome	1.13e-05	0.000206	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	1.13e-05	0.000206	CcSEcCtD
Atazanavir—Nausea—Nevirapine—acquired immunodeficiency syndrome	1.13e-05	0.000206	CcSEcCtD
Atazanavir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	1.13e-05	0.000206	CcSEcCtD
Atazanavir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	1.12e-05	0.000204	CcSEcCtD
Atazanavir—Shock—Lamivudine—acquired immunodeficiency syndrome	1.12e-05	0.000204	CcSEcCtD
Atazanavir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	1.12e-05	0.000203	CcSEcCtD
Atazanavir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	1.11e-05	0.000203	CcSEcCtD
Atazanavir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	1.11e-05	0.000202	CcSEcCtD
Atazanavir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	1.11e-05	0.000202	CcSEcCtD
Atazanavir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	1.11e-05	0.000202	CcSEcCtD
Atazanavir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	1.11e-05	0.000201	CcSEcCtD
Atazanavir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	1.11e-05	0.000201	CcSEcCtD
Atazanavir—Somnolence—Ritonavir—acquired immunodeficiency syndrome	1.1e-05	0.000201	CcSEcCtD
Atazanavir—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	1.1e-05	0.000201	CcSEcCtD
Atazanavir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	1.1e-05	0.0002	CcSEcCtD
Atazanavir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	1.09e-05	0.000199	CcSEcCtD
Atazanavir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	1.09e-05	0.000199	CcSEcCtD
Atazanavir—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	1.09e-05	0.000199	CcSEcCtD
Atazanavir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	1.09e-05	0.000199	CcSEcCtD
Atazanavir—Nausea—Stavudine—acquired immunodeficiency syndrome	1.09e-05	0.000199	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	1.09e-05	0.000198	CcSEcCtD
Atazanavir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	1.09e-05	0.000198	CcSEcCtD
Atazanavir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	1.08e-05	0.000197	CcSEcCtD
Atazanavir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	1.08e-05	0.000196	CcSEcCtD
Atazanavir—Nausea—Abacavir—acquired immunodeficiency syndrome	1.07e-05	0.000196	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	1.07e-05	0.000195	CcSEcCtD
Atazanavir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	1.07e-05	0.000195	CcSEcCtD
Atazanavir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	1.07e-05	0.000194	CcSEcCtD
Atazanavir—Asthenia—Indinavir—acquired immunodeficiency syndrome	1.07e-05	0.000194	CcSEcCtD
Atazanavir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	1.06e-05	0.000194	CcSEcCtD
Atazanavir—Somnolence—Saquinavir—acquired immunodeficiency syndrome	1.06e-05	0.000193	CcSEcCtD
Atazanavir—Pain—Ritonavir—acquired immunodeficiency syndrome	1.06e-05	0.000193	CcSEcCtD
Atazanavir—Constipation—Ritonavir—acquired immunodeficiency syndrome	1.06e-05	0.000193	CcSEcCtD
Atazanavir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	1.06e-05	0.000193	CcSEcCtD
Atazanavir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	1.06e-05	0.000193	CcSEcCtD
Atazanavir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	1.06e-05	0.000192	CcSEcCtD
Atazanavir—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	1.05e-05	0.000191	CcSEcCtD
Atazanavir—Pruritus—Indinavir—acquired immunodeficiency syndrome	1.05e-05	0.000191	CcSEcCtD
Atazanavir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	1.04e-05	0.000189	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	1.04e-05	0.000189	CcSEcCtD
Atazanavir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	1.03e-05	0.000188	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	1.03e-05	0.000188	CcSEcCtD
Atazanavir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	1.03e-05	0.000188	CcSEcCtD
Atazanavir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	1.03e-05	0.000188	CcSEcCtD
Atazanavir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	1.02e-05	0.000186	CcSEcCtD
Atazanavir—Constipation—Saquinavir—acquired immunodeficiency syndrome	1.02e-05	0.000186	CcSEcCtD
Atazanavir—Pain—Saquinavir—acquired immunodeficiency syndrome	1.02e-05	0.000186	CcSEcCtD
Atazanavir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	1.02e-05	0.000185	CcSEcCtD
Atazanavir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	1.02e-05	0.000185	CcSEcCtD
Atazanavir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	1.01e-05	0.000185	CcSEcCtD
Atazanavir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	1.01e-05	0.000185	CcSEcCtD
Atazanavir—Somnolence—Lamivudine—acquired immunodeficiency syndrome	1.01e-05	0.000184	CcSEcCtD
Atazanavir—Rash—Zidovudine—acquired immunodeficiency syndrome	1.01e-05	0.000183	CcSEcCtD
Atazanavir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	1.01e-05	0.000183	CcSEcCtD
Atazanavir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	1.01e-05	0.000183	CcSEcCtD
Atazanavir—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	1e-05	0.000183	CcSEcCtD
Atazanavir—Headache—Zidovudine—acquired immunodeficiency syndrome	1e-05	0.000182	CcSEcCtD
Atazanavir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.92e-06	0.000181	CcSEcCtD
Atazanavir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.91e-06	0.00018	CcSEcCtD
Atazanavir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.89e-06	0.00018	CcSEcCtD
Atazanavir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.86e-06	0.00018	CcSEcCtD
Atazanavir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.84e-06	0.000179	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.84e-06	0.000179	CcSEcCtD
Atazanavir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.82e-06	0.000179	CcSEcCtD
Atazanavir—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.82e-06	0.000179	CcSEcCtD
Atazanavir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.81e-06	0.000179	CcSEcCtD
Atazanavir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.81e-06	0.000179	CcSEcCtD
Atazanavir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.77e-06	0.000178	CcSEcCtD
Atazanavir—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.74e-06	0.000177	CcSEcCtD
Atazanavir—Pain—Lamivudine—acquired immunodeficiency syndrome	9.74e-06	0.000177	CcSEcCtD
Atazanavir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.63e-06	0.000175	CcSEcCtD
Atazanavir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.6e-06	0.000175	CcSEcCtD
Atazanavir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.49e-06	0.000173	CcSEcCtD
Atazanavir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.49e-06	0.000173	CcSEcCtD
Atazanavir—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.48e-06	0.000173	CcSEcCtD
Atazanavir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.44e-06	0.000172	CcSEcCtD
Atazanavir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.44e-06	0.000172	CcSEcCtD
Atazanavir—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.44e-06	0.000172	CcSEcCtD
Atazanavir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.39e-06	0.000171	CcSEcCtD
Atazanavir—Rash—Indinavir—acquired immunodeficiency syndrome	9.36e-06	0.00017	CcSEcCtD
Atazanavir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.35e-06	0.00017	CcSEcCtD
Atazanavir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.32e-06	0.00017	CcSEcCtD
Atazanavir—Headache—Indinavir—acquired immunodeficiency syndrome	9.3e-06	0.000169	CcSEcCtD
Atazanavir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.28e-06	0.000169	CcSEcCtD
Atazanavir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.18e-06	0.000167	CcSEcCtD
Atazanavir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.14e-06	0.000166	CcSEcCtD
Atazanavir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.05e-06	0.000165	CcSEcCtD
Atazanavir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.01e-06	0.000164	CcSEcCtD
Atazanavir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.01e-06	0.000164	CcSEcCtD
Atazanavir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.92e-06	0.000162	CcSEcCtD
Atazanavir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.9e-06	0.000162	CcSEcCtD
Atazanavir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.87e-06	0.000162	CcSEcCtD
Atazanavir—Rash—Efavirenz—acquired immunodeficiency syndrome	8.84e-06	0.000161	CcSEcCtD
Atazanavir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.84e-06	0.000161	CcSEcCtD
Atazanavir—Nausea—Indinavir—acquired immunodeficiency syndrome	8.82e-06	0.000161	CcSEcCtD
Atazanavir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.8e-06	0.00016	CcSEcCtD
Atazanavir—Headache—Efavirenz—acquired immunodeficiency syndrome	8.79e-06	0.00016	CcSEcCtD
Atazanavir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.78e-06	0.00016	CcSEcCtD
Atazanavir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.57e-06	0.000156	CcSEcCtD
Atazanavir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.53e-06	0.000155	CcSEcCtD
Atazanavir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.49e-06	0.000155	CcSEcCtD
Atazanavir—Rash—Delavirdine—acquired immunodeficiency syndrome	8.46e-06	0.000154	CcSEcCtD
Atazanavir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.45e-06	0.000154	CcSEcCtD
Atazanavir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.45e-06	0.000154	CcSEcCtD
Atazanavir—Headache—Delavirdine—acquired immunodeficiency syndrome	8.41e-06	0.000153	CcSEcCtD
Atazanavir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.4e-06	0.000153	CcSEcCtD
Atazanavir—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.33e-06	0.000152	CcSEcCtD
Atazanavir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.21e-06	0.000149	CcSEcCtD
Atazanavir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.18e-06	0.000149	CcSEcCtD
Atazanavir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.17e-06	0.000149	CcSEcCtD
Atazanavir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.06e-06	0.000147	CcSEcCtD
Atazanavir—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.97e-06	0.000145	CcSEcCtD
Atazanavir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.9e-06	0.000144	CcSEcCtD
Atazanavir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.89e-06	0.000144	CcSEcCtD
Atazanavir—Rash—Ritonavir—acquired immunodeficiency syndrome	7.82e-06	0.000142	CcSEcCtD
Atazanavir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.82e-06	0.000142	CcSEcCtD
Atazanavir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.8e-06	0.000142	CcSEcCtD
Atazanavir—Headache—Ritonavir—acquired immunodeficiency syndrome	7.77e-06	0.000142	CcSEcCtD
Atazanavir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.59e-06	0.000138	CcSEcCtD
Atazanavir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.54e-06	0.000137	CcSEcCtD
Atazanavir—Rash—Saquinavir—acquired immunodeficiency syndrome	7.53e-06	0.000137	CcSEcCtD
Atazanavir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.52e-06	0.000137	CcSEcCtD
Atazanavir—Headache—Saquinavir—acquired immunodeficiency syndrome	7.48e-06	0.000136	CcSEcCtD
Atazanavir—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.37e-06	0.000134	CcSEcCtD
Atazanavir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.25e-06	0.000132	CcSEcCtD
Atazanavir—Rash—Lamivudine—acquired immunodeficiency syndrome	7.18e-06	0.000131	CcSEcCtD
Atazanavir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.18e-06	0.000131	CcSEcCtD
Atazanavir—Headache—Lamivudine—acquired immunodeficiency syndrome	7.14e-06	0.00013	CcSEcCtD
Atazanavir—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.09e-06	0.000129	CcSEcCtD
Atazanavir—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.77e-06	0.000123	CcSEcCtD
Atazanavir—SLCO1B3—vagina—acquired immunodeficiency syndrome	3.6e-06	0.111	CbGeAlD
Atazanavir—SLCO1B3—lung—acquired immunodeficiency syndrome	3.41e-06	0.105	CbGeAlD
Atazanavir—CYP2C9—blood plasma—acquired immunodeficiency syndrome	3.1e-06	0.0954	CbGeAlD
Atazanavir—CYP3A4—blood plasma—acquired immunodeficiency syndrome	2.36e-06	0.0727	CbGeAlD
Atazanavir—ABCB1—blood plasma—acquired immunodeficiency syndrome	1.67e-06	0.0515	CbGeAlD
Atazanavir—ABCC1—blood—acquired immunodeficiency syndrome	1.5e-06	0.0462	CbGeAlD
Atazanavir—ABCC1—vagina—acquired immunodeficiency syndrome	1.39e-06	0.0428	CbGeAlD
Atazanavir—ABCC1—lung—acquired immunodeficiency syndrome	1.32e-06	0.0405	CbGeAlD
Atazanavir—CYP2C9—digestive system—acquired immunodeficiency syndrome	1.19e-06	0.0367	CbGeAlD
Atazanavir—CYP2C9—blood—acquired immunodeficiency syndrome	1.14e-06	0.0349	CbGeAlD
Atazanavir—ABCC1—brain—acquired immunodeficiency syndrome	9.32e-07	0.0287	CbGeAlD
Atazanavir—ABCB1—retina—acquired immunodeficiency syndrome	9.17e-07	0.0282	CbGeAlD
Atazanavir—CYP3A4—digestive system—acquired immunodeficiency syndrome	9.09e-07	0.028	CbGeAlD
Atazanavir—ABCC1—lymph node—acquired immunodeficiency syndrome	9.01e-07	0.0277	CbGeAlD
Atazanavir—CYP3A4—blood—acquired immunodeficiency syndrome	8.66e-07	0.0266	CbGeAlD
Atazanavir—CYP3A4—nervous system—acquired immunodeficiency syndrome	7.03e-07	0.0216	CbGeAlD
Atazanavir—CYP3A4—central nervous system—acquired immunodeficiency syndrome	6.77e-07	0.0208	CbGeAlD
Atazanavir—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	6.52e-07	0.02	CbGeAlD
Atazanavir—ABCB1—digestive system—acquired immunodeficiency syndrome	6.44e-07	0.0198	CbGeAlD
Atazanavir—ABCB1—blood—acquired immunodeficiency syndrome	6.13e-07	0.0189	CbGeAlD
Atazanavir—ABCB1—bone marrow—acquired immunodeficiency syndrome	5.93e-07	0.0182	CbGeAlD
Atazanavir—ABCB1—spinal cord—acquired immunodeficiency syndrome	5.91e-07	0.0182	CbGeAlD
Atazanavir—ABCB1—vagina—acquired immunodeficiency syndrome	5.68e-07	0.0175	CbGeAlD
Atazanavir—ABCB1—lung—acquired immunodeficiency syndrome	5.38e-07	0.0165	CbGeAlD
Atazanavir—ABCB1—nervous system—acquired immunodeficiency syndrome	4.98e-07	0.0153	CbGeAlD
Atazanavir—ABCB1—central nervous system—acquired immunodeficiency syndrome	4.79e-07	0.0147	CbGeAlD
Atazanavir—ABCB1—brain—acquired immunodeficiency syndrome	3.8e-07	0.0117	CbGeAlD
Atazanavir—ABCB1—lymph node—acquired immunodeficiency syndrome	3.68e-07	0.0113	CbGeAlD
